BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 27687692)

  • 61. A rare composite lymphoma: follicular and in situ mantle cell.
    Marí-Jimenez P; Martínez-Losada C; Centeno-Haro M; Rodríguez-García G; Perez-Seoane C; Sánchez-García J
    Ann Hematol; 2016 Aug; 95(8):1351-2. PubMed ID: 27103006
    [No Abstract]   [Full Text] [Related]  

  • 62. The long term follow-up of early stage follicular lymphoma treated with radiotherapy, chemotherapy or combined modality treatment.
    Sancho JM; García O; Mercadal S; Pomares H; Fernández-Alvarez R; González-Barca E; Tapia G; González-García E; Moreno M; Domingo-Domènech E; Sorigué M; Navarro JT; Motlló C; Fernández-de-Sevilla A; Feliu E; Ribera JM
    Leuk Res; 2015 Aug; 39(8):853-8. PubMed ID: 26122511
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Fludarabine-mitoxantrone-rituximab regimen in untreated intermediate/high-risk follicular non-Hodgkin's lymphoma: experience on 142 patients.
    Zinzani PL; Pellegrini C; Broccoli A; Casadei B; Argnani L; Pileri S
    Am J Hematol; 2013 Nov; 88(11):E273-6. PubMed ID: 23843267
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Multiple Polypoid Lesions in the Ileum After Treatment for Primary Ileal Follicular Lymphoma.
    Kitamoto H; Kataoka T; Yamamoto S
    Gastroenterology; 2019 Feb; 156(3):552-553. PubMed ID: 30201345
    [No Abstract]   [Full Text] [Related]  

  • 65. Increase of peripheral blood CD57+ T-cells in patients with oral squamous cell carcinoma.
    Iida M; Takayama E; Naganawa K; Mitsudo K; Adachi M; Baba J; Fujimoto-Muto M; Motohashi M; Mizuno-Kamiya M; Kawaki H; Kioi M; Ichinose M; Sumitomo S; Muramatsu Y; Shikimori M; Tohnai I; Kondoh N
    Anticancer Res; 2014 Oct; 34(10):5729-34. PubMed ID: 25275081
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical features of patients with nodal marginal zone lymphoma compared to follicular lymphoma: similar presentation, but differences in prognostic factors and rate of transformation.
    van den Brand M; van der Velden WJ; Diets IJ; Ector GI; de Haan AF; Stevens WB; Hebeda KM; Groenen PJ; van Krieken HJ
    Leuk Lymphoma; 2016 Jul; 57(7):1649-56. PubMed ID: 26694256
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Durable event-free survival following autologous stem cell transplant for relapsed or refractory follicular lymphoma: positive impact of recent rituximab exposure and low-risk Follicular Lymphoma International Prognostic Index score.
    Peters AC; Duan Q; Russell JA; Duggan P; Owen C; Stewart DA
    Leuk Lymphoma; 2011 Nov; 52(11):2124-9. PubMed ID: 21740097
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Improvement of overall and failure-free survival in stage IV follicular lymphoma: 25 years of treatment experience at The University of Texas M.D. Anderson Cancer Center.
    Liu Q; Fayad L; Cabanillas F; Hagemeister FB; Ayers GD; Hess M; Romaguera J; Rodriguez MA; Tsimberidou AM; Verstovsek S; Younes A; Pro B; Lee MS; Ayala A; McLaughlin P
    J Clin Oncol; 2006 Apr; 24(10):1582-9. PubMed ID: 16575009
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Weight change trends and overall survival in United States veterans with follicular lymphoma treated with chemotherapy.
    Xiao DY; Luo S; O'Brian K; Liu W; Carson KR
    Leuk Lymphoma; 2017 Apr; 58(4):851-858. PubMed ID: 27669828
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The reliability of immunohistochemical analysis of the tumor microenvironment in follicular lymphoma: a validation study from the Lunenburg Lymphoma Biomarker Consortium.
    Sander B; de Jong D; Rosenwald A; Xie W; Balagué O; Calaminici M; Carreras J; Gaulard P; Gribben J; Hagenbeek A; Kersten MJ; Molina TJ; Lee A; Montes-Moreno S; Ott G; Raemaekers J; Salles G; Sehn L; Thorns C; Wahlin BE; Gascoyne RD; Weller E
    Haematologica; 2014 Apr; 99(4):715-25. PubMed ID: 24510338
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The role of anthracyclines in combination chemotherapy for the treatment of follicular lymphoma: retrospective study of the Intergruppo Italiano Linfomi on 761 cases.
    Rigacci L; Federico M; Martelli M; Zinzani PL; Cavanna L; Bellesi G; Merli F; Alterini R; Petrucci MT; Tani M; Liberati AM; Vitolo U; Pavone V; Cuneo A; Chisesib T; Brugiatelli M;
    Leuk Lymphoma; 2003 Nov; 44(11):1911-7. PubMed ID: 14738142
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparative flow immunophenotypic features of the inflammatory infiltrates of Hodgkin lymphoma and lymphoid hyperplasia.
    Hudnall SD; Betancourt E; Barnhart E; Patel J
    Cytometry B Clin Cytom; 2008 Jan; 74(1):1-8. PubMed ID: 18061945
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Primary follicular lymphoma of the gastrointestinal tract.
    Misdraji J; Harris NL; Hasserjian RP; Lauwers GY; Ferry JA
    Am J Surg Pathol; 2011 Sep; 35(9):1255-63. PubMed ID: 21836483
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Diagnostic and prognostic utility of t(14;18) in follicular lymphoma.
    Deghiedy H; Fouda M; Shahin D; Shamaa S; El-Bedewy A; Abd El-Ghaffar H
    Acta Haematol; 2007; 118(4):231-6. PubMed ID: 18075243
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Leukemic phase of follicular lymphomas: an atypical presentation.
    Al-Nawakil C; Kosmider O; Stern MH; Manié E; Bardet V; Leblond V; Park S; Dreyfus F; Bouscary D; Tamburini J
    Leuk Lymphoma; 2011 Aug; 52(8):1504-8. PubMed ID: 21585282
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Validation, revision and extension of the Follicular Lymphoma International Prognostic Index (FLIPI) in a population-based setting.
    van de Schans SA; Steyerberg EW; Nijziel MR; Creemers GJ; Janssen-Heijnen ML; van Spronsen DJ
    Ann Oncol; 2009 Oct; 20(10):1697-702. PubMed ID: 19549712
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Low NK cell counts in peripheral blood are associated with inferior overall survival in patients with follicular lymphoma.
    Shafer D; Smith MR; Borghaei H; Millenson MM; Li T; Litwin S; Anad R; Al-Saleem T
    Leuk Res; 2013 Oct; 37(10):1213-5. PubMed ID: 23968916
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Lack of intrafollicular memory CD4 + T cells is predictive of early clinical failure in newly diagnosed follicular lymphoma.
    Mondello P; Fama A; Larson MC; Feldman AL; Villasboas JC; Yang ZZ; Galkin I; Svelolkin V; Postovalova E; Bagaev A; Ovcharov P; Varlamova A; Huet S; Tesson B; McGrath KR; Slager S; Link BK; Syrbu S; Novak AJ; Habermann TM; Witzig TE; Nowakowski GS; Salles G; Cerhan JR; Ansell SM
    Blood Cancer J; 2021 Jul; 11(7):130. PubMed ID: 34267181
    [TBL] [Abstract][Full Text] [Related]  

  • 79. T-cell phenotype including CD57
    Yang ZZ; Kim HJ; Wu H; Tang X; Yu Y; Krull J; Larson DP; Moore RM; Maurer MJ; Pavelko KD; Jalali S; Pritchett JC; Mudappathi R; Wang J; Villasboas JC; Mondello P; Novak AJ; Ansell SM
    Blood Cancer J; 2023 Aug; 13(1):124. PubMed ID: 37591873
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Non-malignant T-cells lacking multiple pan-T markers can be found in lymph nodes.
    Wang W; Gao L; Gong M; Tang Y; Li Y; Zhang WT; Huang FZ; Zhang CX; Chen YR; Gao YY; Li ZL; Ma YG
    Leuk Lymphoma; 2018 Jan; 59(1):155-161. PubMed ID: 26293843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.